Products

Names and Compounds of our Products

Lundbeck has a broad range of products within brain diseases. With registered products in more than 100 countries, we leverage our global presence to bring innovative therapies to people living with brain diseases around the world.

Neurological Disorders
Disease Area	Trademark	Compound
Migraine	Vyepti®	Eptinezumab
Parkinson's disease	Azilect®	Rasagiline
Alzheimer's disease	Ebixa®	Memantine

Psychiatric Disorders
Disease Area	Trademark	Compound
Psychosis	Clopixol Depot®	Zuclopenthixoldecanoate
	Fluanxol Depot®	Cis(Z)-Flupenticoldecanoate
	Rexulti®	Brexpiprazole
Depression, Anxiety	Lexapro®	Escitalopram Oxalate
	Rexulti®	Brexpiprazole
	Brintellix®	Vortioxetine
	Deanxit®	Flupentixol + melitracene
Schizophrenia	Abilify Maintena®	Aripiprazole
Bipolar Disorder	Abilify Maintena®	Aripiprazole

Report an Adverse Drug Reaction

Reporting of potential adverse drug reactions is important in order for us to continuously evaluate the benefits and risks of our products and take proactive action as warranted.

Report an Adverse Drug Reaction

More from lundbeck

Research and Development

R&D of new and improved treatments is at the core of what we do.

Learn more

Patients

We see patients as people and are committed to support the person behind.

Learn more

Pipeline

Discover our projects and compounds in development.

Learn more